|
|
| Formerly known as: |
| Volcano Therapeutics, Inc. |
 |
| Primary Symbols & Exchanges: |
| VOLC - NASDAQ |
| - Berlin-Bremen Stock Exchange |
|
|
| Primary Industry: |
| Medical Devices & Diagnostics |
|
|
SIC Industry Code:
|
|
NAICS Industry Code:
|
|
Thomson Financial Business Description:
| The Group's principal activities are to develop, manufacture and commercialize a broad suite of intravascular ultrasound (IVUS) and functional measurement products enhance the diagnosis and treatment of vascular and structural heart disease. The Group has 69 direct sales professional in the United States and 12 direct sales professional in Western Europe and 1 direct sales professional responsible for Asia, the Pacific Ocean region and Latin America countries. In addition, the Group has 38 distribution relationships in 27 other countries. As of December 2007, the Group has 191 owned or licensed US and international patents and 154 applications for owned or licensed patents. |
|
Alacra Alerts:
 
|
Receive alerts on the latest reports on Volcano Corporation
Subscribe to Alacra Alerts via RSS and never miss the latest research on your favorite companies. Just click the images above to add the feed directly to your favorite newsreader.
|
|
